Discovery of ascorbic and phytic acid benefits to reduce sun damage in early stages

By Andrew McDougall

- Last updated on GMT

Stabilization effect of l-ascorbic acid + phytic acid and the aggravation effect of vehicle before and after 5 months treatment
Stabilization effect of l-ascorbic acid + phytic acid and the aggravation effect of vehicle before and after 5 months treatment

Related tags Acid

Scientists in France have discovered that treatment with l-ascorbic acid and phytic acid could reduce the signs of sun damage, although further testing will be needed before cosmetic application can occur.

Published in the Journal of Cosmetics Dermatology, the researchers found that use of the two acids, found in bran and seeds, was significantly more efficacious than a vehicle in many respects in treating solar lentigines (SL), benign signs of sun damage.

Understanding sun damage

The cause of SL is poorly understood, according to the scientists, but evidence suggests the involvement of increased melanin synthesis, distribution, and turnover.

Topical treatments for SL generally interrupt the biosynthesis of melanin through one or more of these mechanisms.

And the study states that l-ascorbic acid (10 per cent) and phytic acid (2 per cent) have been shown to act synergistically at four different levels to block the cascade of reactions leading to the formation of melanin.

Test methods

The scientists conducted a double blind, vehicle-controlled trial in 30 healthy subjects with at least two benign signs of sun damage.

Subjects were randomly assigned to apply a treatment of L-ascorbic acid 10 per cent and phytic acid 2 per cent to one side of the body, as well as another vehicle to the other side twice daily for three months with follow-up of two months.

They found that the pigmentation index for product-treated SL was reduced (maximum reduction 1.3 at three months), whilst the vehicle-treated lesions remained stable.

Further testing will be needed

Fifteen subjects were reported to have experienced 23 adverse events; six (mostly halo depigmentation) were judged possibly related to the study drug.

There were six instances of mild-to-moderate intolerance in the study drug group and five in the vehicle-treated group.

This all lead the researchers to state that future, larger studies are needed to confirm these results and to compare the product with gold-standard treatments.

Khemis, A., Cabou, J., Dubois, J. and Ortonne, J.-P. (2011), A randomized controlled study to evaluate the depigmenting activity of l-ascorbic acid plus phytic acid – serum vs. placebo on solar lentigines. Journal of Cosmetic Dermatology, 10: 266–272. doi: 10.1111/j.1473-2165.2011.00588.

Related news

Show more

Related products

show more

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Related suppliers

Follow us

Products

View more

Webinars

Podcast

Beauty 4.0 Podcast